Reduced MLH3 Expression in the Syndrome of Gan-Shen Yin Deficiency in Patients with Different Diseases

Table 1

Distribution of patients in age, gender, and clinical characteristics.

	Variables	Gan-shen Yin deficiency	Non-gan-shen Yin deficiency	value
PLC	Age (years)
	≤30	1	0
	31–50	14	11
	51–70	10	13
	>70	0	1
	Gender
	Male/female	24/1	22/3
	Tumor size
	≤5 cm	25	25
	AFP level
	>400	16	11
	Liver cirrhosis
	Yes	17	13
	No	8	12
HBP	Age (years)
	≤40	2	1
	41–80	41	47
	>80	1	2
	Gender
	Male/female	30/14	34/16
	Duration of HBP (years)
	<5	12	13
	5–10	23	24
	11–20	6	6
	>20	3	7
	Classification of hypertension
	Class I	5	3
	Class II	28	33
	Class III	11	14
DM	Age (years)
	<40	8	9
	40–60	24	21
	61–80	14	16
	>80	4	4
	Gender
	Male/female	36/14	35/15
	Duration of DM (years)
	<5	24	21
	5–10	12	13
	11–20	10	12
	>20	4	4
	BMI (Kg/m^2)

compared with non-gan-shen Yin deficiency group.